Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Galmarini, Carlos María
131  Ergebnisse:
Personensuche X
?
1

Editorial: Ageing and Carcinogenesis:

Ruggiero, Raúl A. ; Chiarella, Paula ; Galmarini, Carlos María
Frontiers in Oncology.  12 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
2

Aplidin (plitidepsin) is a novel anti-myeloma agent with po..:

Delgado-Calle, Jesus ; Kurihara, Noriyoshi ; Atkinson, Emily G....
Oncotarget.  10 (2019)  28 - p. 2709-2721 , 2019
Link: https://doi.org/10.18632..
 
?
3

Molecular basis of resistance to the microtubule-depolymeri..:

Pantazopoulou, Areti ; Galmarini, Carlos María ; Peñalva, Miguel A.
Scientific Reports.  8 (2018)  1 - p. , 2018
Link: https://doi.org/10.1038/..
 
?
4

Correction: The PARP inhibitor olaparib enhances the sensit..:

Ordóñez, José Luis ; Amaral, Ana Teresa ; Carcaboso, Angel M....
Oncotarget.  8 (2017)  26 - p. 43592-43592 , 2017
Link: https://doi.org/10.18632..
 
?
5

Lurbinectedin induces depletion of tumor-associated macroph..:

Céspedes, María Virtudes ; Guillén, María José ; López-Casas, Pedro Pablo...
Disease Models & Mechanisms.  , 2016
Link: https://doi.org/10.1242/..
 
?
6

The PARP inhibitor olaparib enhances the sensitivity of Ewi..:

Ordóñez, José Luis ; Amaral, Ana Teresa ; Carcaboso, Angel M....
Oncotarget.  6 (2015)  22 - p. 18875-18890 , 2015
Link: https://doi.org/10.18632..
 
?
7

βIII-Tubulin is required for interphase microtubule dynamic..:

Bouchet, Benjamin Pierre ; Puisieux, Alain ; Galmarini, Carlos María
European Journal of Cell Biology.  90 (2011)  10 - p. 872-878 , 2011
Link: https://doi.org/10.1016/..
 
?
8

p21Cip1 regulates cell–substrate adhesion and interphase mi..:

Bouchet, Benjamin Pierre ; Fauvet, Frédérique ; Grelier, Gaël..
European Journal of Cell Biology.  90 (2011)  8 - p. 631-641 , 2011
Link: https://doi.org/10.1016/..
 
?
9

Molecular pharmacology and antitumor activity of Zalypsis® ..:

Leal, Juan F.M. ; García-Hernández, Verónica ; Moneo, Victoria...
Biochemical Pharmacology.  78 (2009)  2 - p. 162-170 , 2009
Link: https://doi.org/10.1016/..
 
?
10

Modulation of the human equilibrative nucleoside transporte..:

Fernández Calotti, Paula ; Galmarini, Carlos María ; Cañones, Cristian...
Biochemical Pharmacology.  75 (2008)  4 - p. 857-865 , 2008
Link: https://doi.org/10.1016/..
 
?
11

Does p16ink4a expression increase with the number of cell d..:

Chebel, Amel ; Chien, Wei-Wen ; Gerland, Luc-Marie...
Leukemia Research.  31 (2007)  12 - p. 1649-1658 , 2007
Link: https://doi.org/10.1016/..
 
?
12

A p21/WAF1 mutation favors the appearance of drug resistanc..:

Galmarini, Carlos María ; Bouchet, Benjamin Pierre ; Audoynaud, Carole...
International Journal of Cancer.  119 (2006)  1 - p. 60-66 , 2006
Link: https://doi.org/10.1002/..
 
?
13

p53 as a target for anti-cancer drug development:

Bouchet, Benjamin Pierre ; de Fromentel, Claude Caron ; Puisieux, Alain.
Critical Reviews in Oncology/Hematology.  58 (2006)  3 - p. 190-207 , 2006
Link: https://doi.org/10.1016/..
 
?
14

Mutational Targets in Colorectal Cancer Cells with Microsat..:

Bertholon, Jacques ; Wang, Qing ; Galmarini, Carlos Maria.
Familial Cancer.  5 (2006)  1 - p. 29-34 , 2006
Link: https://doi.org/10.1007/..
 
?
15

Deoxycytidine kinase and cN‐II nucleotidase expression in b..:

Galmarini, Carlos María ; Thomas, Xavier ; Graham, Kathryn...
British Journal of Haematology.  122 (2003)  1 - p. 53-60 , 2003
Link: https://doi.org/10.1046/..
 
1-15